Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Brand Medicine -

Brand Medicine

The Role of Branding in the Pharmaceutical Industry

T. Blackett, R. Robins (Herausgeber)

Buch | Softcover
308 Seiten
2001 | 1st ed. 2001
Palgrave Macmillan (Verlag)
978-1-349-42588-4 (ISBN)
CHF 74,85 inkl. MwSt
As governments seek to mitigate the cost of state-subsidised healthcare, branding in the pharmaceutical industry has become a critical issue. This book by Interbrand Newell and Sorrell, the world's leading branding consultancy, provides cutting edge thinking on this area and lessons for anyone involved in brand development and management.
As governments seek to mitigate the cost of state-subsidised healthcare, branding in the pharmaceutical industry has become a critical issue. Drugs companies must change their methods of communication and distribution - focusing more on their direct relationship with the consumer. This requires fundamental changes in consumer behaviour, access to information, freedom of choice and value for money. Brands and brand values will play a leading role in this process, as has been seen with products such as Prozac and Viagra. This book by Interbrand Newell and Sorrell, the world's leading branding consultancy, provides cutting edge thinking on this area and lessons for anyone involved in brand development and management.

TOM BLACKETT is Group Deputy Chairman of Interbrand. He is the author of, Trademarks and the co-author of, Co-Branding, both published by Palgrave. REBECCA ROBINS is a Senior Consultant of Interbrand Healthcare in New York. Prior to joining the New York office, she worked in the London office of Interbrand for four years.

Introduction The Development of Branding as a Key Business Strategy Clinical Development and Branding Pharmaceutical Brand Name Development Brand Packaging Design Packaging for the Elderly The Role of Advertising in Branding Pharmaceuticals Direct to Consumer Branding: The US Perspective Direct to Consumer Branding: Europe and Asia Public Relations and its Role in Pharmaceutical Brand Building The Rx to OTC Switch: Creating the Climate for Change Successful 'Switch' Strategies Trade Mark Legal Issues Regulatory Issues The Government View The Valuation of Pharmaceutical Brands Nutraceuticals The Future of Branding in the Pharmaceutical Industry

Erscheinungsdatum
Zusatzinfo 155 Illustrations, black and white; XXVII, 308 p. 155 illus.
Verlagsort Basingstoke
Sprache englisch
Maße 152 x 229 mm
Themenwelt Wirtschaft Betriebswirtschaft / Management Marketing / Vertrieb
Wirtschaft Betriebswirtschaft / Management Unternehmensführung / Management
Wirtschaft Volkswirtschaftslehre
Schlagworte Distribution
ISBN-10 1-349-42588-5 / 1349425885
ISBN-13 978-1-349-42588-4 / 9781349425884
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Grundlagen marktorientierter Unternehmensführung : Konzepte, …

von Heribert Meffert; Christoph Burmann; Manfred Kirchgeorg

Buch (2024)
Springer Gabler (Verlag)
CHF 69,95
Marketinginstrumente und Erkenntnisse der Wirtschaftspsychologie

von Katja Gelbrich; Stefan Müller

Buch | Softcover (2024)
Vahlen (Verlag)
CHF 34,85
neueste Konzepte, Strategien und Technologien sowie praxiserprobte …

von Uwe Seebacher

Buch | Hardcover (2023)
Springer Gabler (Verlag)
CHF 153,95